How many institutions held IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in Q4 2023?

227 institutional investors reported IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Q: What does CUSIP 45258J102 represent in this 13F holders report?

CUSIP 45258J102 is the security identifier for IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45258J102

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 202,731,676
Total 13F shares: 68,405,672
Share change: +289,944
Total reported value: $2,881,981,571
Put/Call ratio: 55%
Price per share: $42.13
Number of holders: 227
Value change: +$25,897,847
Number of buys: 126
Number of sells: 96

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 45258J102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	3.8%	7,748,546	$297,466,681	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	3.1%	6,233,146	$239,290,475	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	2%	4,131,665	$158,614,622	—	30 Sep 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.9%	3,814,691	$146,445,987	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	1.7%	3,468,617	$133,160,207	—	30 Sep 2023	13F
Deep Track Capital, LP	13F	Company	1.4%	2,797,955	$107,413,492	—	30 Sep 2023	13F
Darwin Global Management, Ltd.	13F	Company	0.9%	1,818,371	$69,807,263	—	30 Sep 2023	13F
Logos Global Management LP	13F	Company	0.79%	1,600,000	$61,424,000	—	30 Sep 2023	13F
Alpine Global Management, LLC	13F	Company	0.62%	1,252,474	$48,082,477	—	30 Sep 2023	13F
Cormorant Asset Management, LP	13F	Company	0.6%	1,225,000	$47,027,750	—	30 Sep 2023	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.59%	1,186,031	$45,531,730	—	30 Sep 2023	13F
Avidity Partners Management LP	13F	Company	0.58%	1,173,662	$45,056,884	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.56%	1,144,334	$43,935,809	—	30 Sep 2023	13F
Pictet Asset Management Holding SA	13F	Company	0.56%	1,135,205	$43,580,520	—	30 Sep 2023	13F
Redmile Group, LLC	13F	Company	0.54%	1,102,514	$42,325,512	—	30 Sep 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.51%	1,035,877	$39,767,318	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.51%	1,028,216	$39,473,211	—	30 Sep 2023	13F
Commodore Capital LP	13F	Company	0.49%	1,000,000	$38,390,000	—	30 Sep 2023	13F
Woodline Partners LP	13F	Company	0.48%	964,083	$37,011,146	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.42%	845,376	$32,453,985	—	30 Sep 2023	13F
Boxer Capital, LLC	13F	Company	0.37%	750,000	$28,792,500	—	30 Sep 2023	13F
Capital Research Global Investors	13F	Company	0.37%	750,000	$28,792,500	—	30 Sep 2023	13F
Fairmount Funds Management LLC	13F	Company	0.37%	750,000	$28,792,500	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.36%	736,529	$28,278,708	—	30 Sep 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.36%	730,042	$28,027,000	—	30 Sep 2023	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.34%	681,935	$26,179,000	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.32%	658,632	$25,284,882	—	30 Sep 2023	13F
Rock Springs Capital Management LP	13F	Company	0.32%	644,344	$24,736,366	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.3%	602,792	$23,141,185	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.3%	600,300	$23,045,517	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.25%	510,440	$19,595,791	—	30 Sep 2023	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.25%	504,000	$19,348,560	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.24%	479,368	$18,402,937	—	30 Sep 2023	13F
PFM Health Sciences, LP	13F	Company	0.23%	472,540	$18,140,811	—	30 Sep 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.21%	434,500	$16,680,455	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.21%	428,508	$16,450,423	—	30 Sep 2023	13F
Two Seas Capital LP	13F	Company	0.21%	427,256	$16,402,358	—	30 Sep 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	0.21%	425,009	$16,316,096	—	30 Sep 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.2%	399,599	$15,340,606	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	387,240	$14,866,144	—	30 Sep 2023	13F
Nicholas Investment Partners, LP	13F	Company	0.19%	378,155	$14,517,370	—	30 Sep 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.18%	372,771	$14,310,678	—	30 Sep 2023	13F
FEDERATED HERMES, INC.	13F	Company	0.18%	359,588	$13,804,583	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.17%	346,396	$13,298,142	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0.17%	338,883	$13,009,717	—	30 Sep 2023	13F
TCG Crossover Management, LLC	13F	Company	0.17%	334,853	$12,855,006	—	30 Sep 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.16%	328,512	$12,611,575	—	30 Sep 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.16%	327,075	$12,556,369	—	30 Sep 2023	13F
JENNISON ASSOCIATES LLC	13F	Company	0.15%	313,191	$12,023,403	—	30 Sep 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.15%	300,000	$11,517,000	—	30 Sep 2023	13F

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2023

As of 31 Dec 2023, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 227 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,405,672 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Point72 Asset Management, L.P., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, ARMISTICE CAPITAL, LLC, Alpine Global Management, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 227 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

179

Q4 2023 holders

227

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.